Literature DB >> 11320826

Clinical features of pharyngeal cancer: a retrospective study of 258 consecutive patients.

A E Uzcudun1, P Bravo Fernández, J J Sánchez, A García Grande, I Rabanal Retolaza, M González Barón, J Gavilán Bouzas.   

Abstract

Pharyngeal cancer still presents an unsatisfactory mortality (30-40 per cent in most series, with a slightly better prognosis for nasopharyngeal cancer relative to both oropharyngeal and hypopharyngeal cancers) despite advances in treatment. Therefore, it is critical to know the clinical features of pharyngeal cancer. The purpose of this study was to investigate the most relevant clinical features of pharyngeal cancer (oropharyngeal, hypopharyngeal, and nasopharyngeal) in order to improve knowledge of this malignancy with the aim of ameliorating diagnosis and treatment. The retrospective study was based on a review of medical records from 258 consecutive patients with pharyngeal cancer (oropharyngeal, hypopharyngeal and nasopharyngeal) diagnosed at La Paz University Hospital, Madrid, Spain, between January 1 1991 and and December 31 1995. Medical records were provided by the Departments of Otorhinolaryngology, Head and Neck Surgery, Radiation Oncology, and Medical Oncology. All medical records were analysed for the following clinical variables: 1) incidence, 2) sociodemographics, 3) sites (oropharynx, hypopharynx, nasopharynx) and subsites, 4) clinical and histological staging, 5) pathology, 6) presenting symptoms, 7) time to diagnosis, 8) patients' general performance status at diagnosis, 9) personal cancer history and synchronous head and neck tumours, 10) premalignant lesions, and 11) paediatric cases. Our most outstanding finding was the excessively long time that elapsed between first clinical manifestation appearance and conclusive diagnosis of pharyngeal cancer (4.7 months for pharynx, 4.5 for oropharynx, 4.4 for hypopharynx and 6.5 for nasopharynx cancers). It was found that nasopharyngeal cancer was quite different from both oropharyngeal and hypopharyngeal cancers with respect to its potential aetiology, risk factors and clinical presentation. In addition it has a better prognosis.

Entities:  

Mesh:

Year:  2001        PMID: 11320826     DOI: 10.1258/0022215011907703

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  4 in total

1.  Synthesis and characterization of ester-diol based polyurethane: a potentiality check for hypopharyngeal tissue engineering application.

Authors:  Imon Chakraborty; Chowdhury Mobaswar Hossain; Piyali Basak
Journal:  Biomed Eng Lett       Date:  2020-11-28

2.  Skeletal muscle regeneration on protein-grafted and microchannel-patterned scaffold for hypopharyngeal tissue engineering.

Authors:  Zhisen Shen; Shanshan Guo; Dong Ye; Jingjing Chen; Cheng Kang; Shejie Qiu; Dakai Lu; Qun Li; Kunjie Xu; Jingjing Lv; Yabin Zhu
Journal:  Biomed Res Int       Date:  2013-09-23       Impact factor: 3.411

3.  Role of neoadjuvant chemotherapy in advanced carcinoma of the hypopharynx and larynx.

Authors:  Poonam Joshi; Amit Joshi; Vanita Norohna; Pankaj Chaturvedi; Vijay Patil; Jai Prakash Agarwal; Shashikant Juvekar; Kumar Prabhash
Journal:  South Asian J Cancer       Date:  2017 Jan-Mar

4.  Alcohol consumption, tobacco smoking, betel quid chewing and oral health associations with hypopharyngeal cancer among men in Central South China: a case-control study.

Authors:  Junfeng Zeng; Yaoyun Tang; Ping Wu; Xing Fang; Wei Wang; Yuhua Fan; Xin Li; Suping Zhao
Journal:  Cancer Manag Res       Date:  2019-07-10       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.